BRAINSTORM CELL THERAPEUTICS's ticker is and the CUSIP is 10501E951. A total of 4 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,151,000 | – | 1,271 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 2,371 | $1,073,000 | 0.21% |
| GROUP ONE TRADING, L.P. | 216,400 | $979,000 | 0.00% |
| SIMPLEX TRADING, LLC | 472 | $213,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |